Cardlytics Stock Z Score
| CDLX Stock | USD 3.93 0.13 3.42% |
Cardlytics | Z Score |
Cardlytics Company Z Score Analysis
Cardlytics' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
Cardlytics Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Cardlytics is extremely important. It helps to project a fair market value of Cardlytics Stock properly, considering its historical fundamentals such as Z Score. Since Cardlytics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cardlytics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cardlytics' interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
In accordance with the company's disclosures, Cardlytics has a Z Score of 0.0. This is 100.0% lower than that of the Media sector and about the same as Communication Services (which currently averages 0.0) industry. The z score for all United States stocks is 100.0% higher than that of the company.
Cardlytics Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardlytics' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardlytics could also be used in its relative valuation, which is a method of valuing Cardlytics by comparing valuation metrics of similar companies.Cardlytics is currently under evaluation in z score category among its peers.
Cardlytics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cardlytics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cardlytics' managers, analysts, and investors.Environmental | Governance | Social |
Cardlytics Institutional Holders
Institutional Holdings refers to the ownership stake in Cardlytics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Cardlytics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cardlytics' value.| Shares | Nuveen Asset Management, Llc | 2024-06-30 | 665.5 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 638 K | D. E. Shaw & Co Lp | 2024-09-30 | 573.3 K | Baillie Gifford & Co Limited. | 2024-09-30 | 567.4 K | General Equity Holdings Lp | 2024-09-30 | 533.5 K | Ubs O'connor Llc | 2024-09-30 | 450 K | Renaissance Technologies Corp | 2024-09-30 | 410.9 K | Pb Investment Partners, L.p. | 2024-09-30 | 397.1 K | Charles Schwab Investment Management Inc | 2024-09-30 | 390.3 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 4.3 M | Blackrock Inc | 2024-06-30 | 3.2 M |
Cardlytics Fundamentals
| Return On Equity | -1.86 | ||||
| Return On Asset | -0.0762 | ||||
| Profit Margin | (0.94) % | ||||
| Operating Margin | (0.25) % | ||||
| Current Valuation | 354.67 M | ||||
| Shares Outstanding | 50.82 M | ||||
| Shares Owned By Insiders | 5.13 % | ||||
| Shares Owned By Institutions | 61.57 % | ||||
| Number Of Shares Shorted | 7.1 M | ||||
| Price To Earning | (3.47) X | ||||
| Price To Book | 2.87 X | ||||
| Price To Sales | 0.68 X | ||||
| Revenue | 309.2 M | ||||
| Gross Profit | 115.42 M | ||||
| EBITDA | (99 M) | ||||
| Net Income | (134.7 M) | ||||
| Cash And Equivalents | 157.04 M | ||||
| Cash Per Share | 4.77 X | ||||
| Total Debt | 266.11 M | ||||
| Debt To Equity | 0.42 % | ||||
| Current Ratio | 0.90 X | ||||
| Book Value Per Share | 1.38 X | ||||
| Cash Flow From Operations | (185 K) | ||||
| Short Ratio | 11.41 X | ||||
| Earnings Per Share | (6.40) X | ||||
| Price To Earnings To Growth | (0.24) X | ||||
| Target Price | 4.4 | ||||
| Number Of Employees | 456 | ||||
| Beta | 1.62 | ||||
| Market Capitalization | 199.73 M | ||||
| Total Asset | 574.14 M | ||||
| Retained Earnings | (1.11 B) | ||||
| Working Capital | 52.78 M | ||||
| Current Asset | 81.93 M | ||||
| Current Liabilities | 52.77 M | ||||
| Net Asset | 574.14 M |
About Cardlytics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cardlytics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardlytics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardlytics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.